- Home
- About
- Products
- E1 Activating
- E2 Conjugating
- E3 Ligase
- Deconjugating
- Proteasome
- Ubiquitin
- All
- Ubiquitin and Ubiquitin Derivatives
- Ubiquitin Chains
- DUB-Resistant, Non-Hydrolyzable Chains
- NH Isopeptide-linked chains
- DCA Linked Chains
- K6-linked Chains (DCA)
- Agarose Bound K6-linked Chains (DCA)
- K11-linked Chains (DCA)
- Agarose Bound K11-linked Chains (DCA)
- K29-linked Chains (DCA)
- Agarose Bound K29-linked Chains (DCA)
- K33-linked Chains (DCA)
- Agarose Bound K33-linked Chains (DCA)
- K48-linked Chains (DCA)
- Agarose Bound K48-linked Chains (DCA)
- K63-linked Chains (DCA)
- Agarose Bound K63-linked Chains (DCA)
- K76-linked Chains (DCA)
- Agarose Bound K76-linked Chains (DCA)
- Ubiquitin Mutants
- Labeled Ubiquitin Proteins
- Antibodies, ELISAs and Kits
- SUMO
- NEDD8
- ISG15
- UFM1
- URM1
- Autophagy
- FAT10
- Inhibitors
- Antibodies
- Kits
- Buffers, Solutions, Standards
- Substrate Proteins
- Affinity Matrices / Proteins
- Fractions
- FUBI
- References
- Orders
- Contact
Unique to Boston Biochem:
- The most comprehensive ubiquitin-related product range available
- Exclusive and dedicated focus on ubiquitin-related research
- Protein biochemistry research and manufacturing facility
- Expertise in protein purification, characterization, modification and assay development
- Specialized products originate and are developed, produced and characterized in-house
- Close collaborative relationship with ubiquitin and related communities
- Scientific expertise allows for rapid expansion into new areas of ubiquitin-related discovery and enables superior technical support
- R&D Systems expertise now handles sales, distribution and logistics
- Allows for 100% focus on new product development
- R&D Systems complementary antibodies, ELISAs and kits complete product offering
- Tocris chemical expertise completes the inhibitor and substrate offering






